Patrick Rivelli
President & CEO

Patrick Rivelli, President & CEO
Patrick has over 25 years of experience leading venture-backed medical device and diagnostics companies. His companies have been acquired by Boston Scientific, Johnson & Johnson, Covidien, and Multi-Cell Corporation. Patrick holds a BA in Economics from Harvard University and an MS in Management from MIT Sloan.

Dr. Cagri Savran
Founder & CSO

Dr. Cagri Savran, Founder & CSO

Cagri is a Professor of Mechanical Engineering and Biomedical Engineering at Purdue University and the inventor of the underlying technology. He has 18 years of experience in inventing and developing biosensors and medical devices and working across multiple disciplines. He has over 20 patents and patent applications on a variety of devices including optical biosensors, biological micromanipulators and high throughput microfluidic systems. Dr. Savran holds a BS in Mechanical Engineering from Purdue University, and an MS and a PhD in Mechanical Engineering from MIT.

Dr. Hur Koser
CTO

Dr. Hur Koser, CTO
Hur is an accomplished physicist, electrical engineer, consultant and entrepreneur. He has extensive experience working with startups, technology companies and research labs as a capable, hands-on technical and business leader. He is highly knowledgeable in life sciences instruments, biomedical sensors, IoT hardware, embedded systems, RTOS, micro and macro- scale disposables, devices, sensors and energy systems. Dr. Koser holds two BS degrees (in Physics and Electrical Engineering), an MS and a PhD degree in Electrical Engineering, all from MIT.

Dr. Chun-Li Chang
Chief Scientist & Lab Director

Dr. Chun Li Chang
Chun-Li is a Research Professor at Purdue University and the co-inventor of Savran Tech’s primary technology. He has 13 years of hands on experience in bioinstrumentation, chemical conjugation, bodily fluid handling, cell culturing, device design and microfabrication as well as technical personnel management. Dr. Chang holds a BS in Electrical Engineering from National Chiao Tung University in Taiwan, and a PhD in Electrical Engineering from Purdue University.

Patrick Rivelli
President & CEO

Patrick Rivelli, President & CEO
Patrick has over 25 years of experience leading venture-backed medical device and diagnostics companies. His companies have been acquired by Boston Scientific, Johnson & Johnson, Covidien, and Multi-Cell Corporation. Patrick holds a BA in Economics from Harvard University and an MS in Management from MIT Sloan.

Dr. Cagri Savran
Founder & CSO

Dr. Cagri Savran, Founder & CSO

Cagri is a Professor of Mechanical Engineering and Biomedical Engineering at Purdue University and the inventor of the underlying technology. He has 18 years of experience in inventing and developing biosensors and medical devices and working across multiple disciplines. He has over 20 patents and patent applications on a variety of devices including optical biosensors, biological micromanipulators and high throughput microfluidic systems. Dr. Savran holds a BS in Mechanical Engineering from Purdue University, and an MS and a PhD in Mechanical Engineering from MIT.

Mark Carthy
Board Member

Mark Carthy

Mark is Managing Partner at Orion Equity Partners LLC. He is a founder and Chairman of AnTolRx, Inc. Mr. Carthy was previously Chairman of Cyberkinetics Neurotechnology Systems, Inc., General Partner in Oxford Bioscience Partners, Chairman of Artesian Therapeutics, Inc., Chief Business Officer by Cubist Pharmaceuticals, Inc., a Principal by Morningside Venture Group LLC, and the Non-Executive Director of PowderMed Ltd. He also served on the board at Astex Therapeutics Ltd., Dendreon Corp., Rexahn Pharmaceuticals, Inc., Xanthus Pharmaceuticals, Inc., Scion Pharmaceuticals, Inc., Dynogen Pharmaceuticals, Inc., Ensemble Therapeutics Corp., ImpactRx, Inc., Solexa, Inc. and Variagenics, Inc. Mr. Carthy received his undergraduate degree from the University College Dublin, a graduate degree from the University of Missouri and an MBA from Harvard Business School.